Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000688034 | SCV000815630 | pathogenic | Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form | 2022-12-20 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the CLCN1 protein in which other variant(s) (p.Arg894*) have been determined to be pathogenic (PMID: 8533761, 8845168, 11840191, 15162127, 18337730, 22094069, 22197187, 26096614, 27614575). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 567845). This premature translational stop signal has been observed in individual(s) with myotonia congenita (PMID: 12661046). This variant is present in population databases (rs780534566, gnomAD 0.005%). This sequence change creates a premature translational stop signal (p.Leu840Valfs*31) in the CLCN1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 149 amino acid(s) of the CLCN1 protein. |
Athena Diagnostics | RCV002473106 | SCV002771093 | pathogenic | not provided | 2022-08-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000688034 | SCV005667258 | pathogenic | Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form | 2024-04-03 | criteria provided, single submitter | clinical testing |